ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Brigatinib API Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-9B18216
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Brigatinib API Market Research Report 2024
BUY CHAPTERS

Global Brigatinib API Market Research Report 2024

Code: QYRE-Auto-9B18216
Report
August 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ALK
Dr. Reddy’s Laboratories
LGC
Cayman Chemical
Conscientia Industrial
Manus Aktteva Biopharma LLP
Selleck
Shandong Sihuan Pharmaceutical
Vasudha Pharma
Hefei Home Sunshine Pharmaceutical Technology
Vitasv Pharma And Chemical
Anqing benro Pharmaceutical
Sandoo Pharmaceuticals and Chemicals

Brigatinib API Market

Brigatinib is an active pharmaceutical ingredient (API) used for the treatment of non-small cell lung cancer (NSCLC) with ALK gene mutations.It is a selective ALK inhibitor that works by blocking the ALK protein.
The global Brigatinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Brigatinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Brigatinib API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Brigatinib API include Dr. Reddy’s Laboratories, Vitasv Pharma And Chemical, LGC, Cayman Chemical, Conscientia Industrial, Manus Aktteva Biopharma LLP, Selleck, Shandong Sihuan Pharmaceutical, Anqing benro Pharmaceutical, Vasudha Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Brigatinib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brigatinib API.
The Brigatinib API market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Brigatinib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brigatinib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Brigatinib API Market Report

Report Metric Details
Report Name Brigatinib API Market
Segment by Type
  • Purity≥99%
  • Purity<99%
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dr. Reddy’s Laboratories, Vitasv Pharma And Chemical, LGC, Cayman Chemical, Conscientia Industrial, Manus Aktteva Biopharma LLP, Selleck, Shandong Sihuan Pharmaceutical, Anqing benro Pharmaceutical, Vasudha Pharma, Hefei Home Sunshine Pharmaceutical Technology, Sandoo Pharmaceuticals and Chemicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Brigatinib API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Brigatinib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Brigatinib API Market report?

Ans: The main players in the Brigatinib API Market are Dr. Reddy’s Laboratories, Vitasv Pharma And Chemical, LGC, Cayman Chemical, Conscientia Industrial, Manus Aktteva Biopharma LLP, Selleck, Shandong Sihuan Pharmaceutical, Anqing benro Pharmaceutical, Vasudha Pharma, Hefei Home Sunshine Pharmaceutical Technology, Sandoo Pharmaceuticals and Chemicals

What are the Application segmentation covered in the Brigatinib API Market report?

Ans: The Applications covered in the Brigatinib API Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Brigatinib API Market report?

Ans: The Types covered in the Brigatinib API Market report are Purity≥99%, Purity<99%

Recommended Reports

Lung Cancer Drugs

Cancer API Markets

General API Markets

1 Brigatinib API Market Overview
1.1 Product Definition
1.2 Brigatinib API by Type
1.2.1 Global Brigatinib API Market Value Comparison by Type (2024-2030)
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Brigatinib API by Application
1.3.1 Global Brigatinib API Market Value by Application (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Brigatinib API Market Size Estimates and Forecasts
1.4.1 Global Brigatinib API Revenue 2019-2030
1.4.2 Global Brigatinib API Sales 2019-2030
1.4.3 Global Brigatinib API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Brigatinib API Market Competition by Manufacturers
2.1 Global Brigatinib API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Brigatinib API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Brigatinib API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Brigatinib API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Brigatinib API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Brigatinib API, Product Type & Application
2.7 Global Key Manufacturers of Brigatinib API, Date of Enter into This Industry
2.8 Global Brigatinib API Market Competitive Situation and Trends
2.8.1 Global Brigatinib API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Brigatinib API Players Market Share by Revenue
2.8.3 Global Brigatinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Brigatinib API Market Scenario by Region
3.1 Global Brigatinib API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Brigatinib API Sales by Region: 2019-2030
3.2.1 Global Brigatinib API Sales by Region: 2019-2024
3.2.2 Global Brigatinib API Sales by Region: 2025-2030
3.3 Global Brigatinib API Revenue by Region: 2019-2030
3.3.1 Global Brigatinib API Revenue by Region: 2019-2024
3.3.2 Global Brigatinib API Revenue by Region: 2025-2030
3.4 North America Brigatinib API Market Facts & Figures by Country
3.4.1 North America Brigatinib API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Brigatinib API Sales by Country (2019-2030)
3.4.3 North America Brigatinib API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Brigatinib API Market Facts & Figures by Country
3.5.1 Europe Brigatinib API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Brigatinib API Sales by Country (2019-2030)
3.5.3 Europe Brigatinib API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Brigatinib API Market Facts & Figures by Region
3.6.1 Asia Pacific Brigatinib API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Brigatinib API Sales by Region (2019-2030)
3.6.3 Asia Pacific Brigatinib API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Brigatinib API Market Facts & Figures by Country
3.7.1 Latin America Brigatinib API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Brigatinib API Sales by Country (2019-2030)
3.7.3 Latin America Brigatinib API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Brigatinib API Market Facts & Figures by Country
3.8.1 Middle East and Africa Brigatinib API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Brigatinib API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Brigatinib API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Brigatinib API Sales by Type (2019-2030)
4.1.1 Global Brigatinib API Sales by Type (2019-2024)
4.1.2 Global Brigatinib API Sales by Type (2025-2030)
4.1.3 Global Brigatinib API Sales Market Share by Type (2019-2030)
4.2 Global Brigatinib API Revenue by Type (2019-2030)
4.2.1 Global Brigatinib API Revenue by Type (2019-2024)
4.2.2 Global Brigatinib API Revenue by Type (2025-2030)
4.2.3 Global Brigatinib API Revenue Market Share by Type (2019-2030)
4.3 Global Brigatinib API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Brigatinib API Sales by Application (2019-2030)
5.1.1 Global Brigatinib API Sales by Application (2019-2024)
5.1.2 Global Brigatinib API Sales by Application (2025-2030)
5.1.3 Global Brigatinib API Sales Market Share by Application (2019-2030)
5.2 Global Brigatinib API Revenue by Application (2019-2030)
5.2.1 Global Brigatinib API Revenue by Application (2019-2024)
5.2.2 Global Brigatinib API Revenue by Application (2025-2030)
5.2.3 Global Brigatinib API Revenue Market Share by Application (2019-2030)
5.3 Global Brigatinib API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dr. Reddy’s Laboratories
6.1.1 Dr. Reddy’s Laboratories Company Information
6.1.2 Dr. Reddy’s Laboratories Description and Business Overview
6.1.3 Dr. Reddy’s Laboratories Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dr. Reddy’s Laboratories Brigatinib API Product Portfolio
6.1.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.2 Vitasv Pharma And Chemical
6.2.1 Vitasv Pharma And Chemical Company Information
6.2.2 Vitasv Pharma And Chemical Description and Business Overview
6.2.3 Vitasv Pharma And Chemical Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vitasv Pharma And Chemical Brigatinib API Product Portfolio
6.2.5 Vitasv Pharma And Chemical Recent Developments/Updates
6.3 LGC
6.3.1 LGC Company Information
6.3.2 LGC Description and Business Overview
6.3.3 LGC Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 LGC Brigatinib API Product Portfolio
6.3.5 LGC Recent Developments/Updates
6.4 Cayman Chemical
6.4.1 Cayman Chemical Company Information
6.4.2 Cayman Chemical Description and Business Overview
6.4.3 Cayman Chemical Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cayman Chemical Brigatinib API Product Portfolio
6.4.5 Cayman Chemical Recent Developments/Updates
6.5 Conscientia Industrial
6.5.1 Conscientia Industrial Company Information
6.5.2 Conscientia Industrial Description and Business Overview
6.5.3 Conscientia Industrial Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Conscientia Industrial Brigatinib API Product Portfolio
6.5.5 Conscientia Industrial Recent Developments/Updates
6.6 Manus Aktteva Biopharma LLP
6.6.1 Manus Aktteva Biopharma LLP Company Information
6.6.2 Manus Aktteva Biopharma LLP Description and Business Overview
6.6.3 Manus Aktteva Biopharma LLP Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Manus Aktteva Biopharma LLP Brigatinib API Product Portfolio
6.6.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
6.7 Selleck
6.7.1 Selleck Company Information
6.7.2 Selleck Description and Business Overview
6.7.3 Selleck Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Selleck Brigatinib API Product Portfolio
6.7.5 Selleck Recent Developments/Updates
6.8 Shandong Sihuan Pharmaceutical
6.8.1 Shandong Sihuan Pharmaceutical Company Information
6.8.2 Shandong Sihuan Pharmaceutical Description and Business Overview
6.8.3 Shandong Sihuan Pharmaceutical Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shandong Sihuan Pharmaceutical Brigatinib API Product Portfolio
6.8.5 Shandong Sihuan Pharmaceutical Recent Developments/Updates
6.9 Anqing benro Pharmaceutical
6.9.1 Anqing benro Pharmaceutical Company Information
6.9.2 Anqing benro Pharmaceutical Description and Business Overview
6.9.3 Anqing benro Pharmaceutical Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Anqing benro Pharmaceutical Brigatinib API Product Portfolio
6.9.5 Anqing benro Pharmaceutical Recent Developments/Updates
6.10 Vasudha Pharma
6.10.1 Vasudha Pharma Company Information
6.10.2 Vasudha Pharma Description and Business Overview
6.10.3 Vasudha Pharma Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vasudha Pharma Brigatinib API Product Portfolio
6.10.5 Vasudha Pharma Recent Developments/Updates
6.11 Hefei Home Sunshine Pharmaceutical Technology
6.11.1 Hefei Home Sunshine Pharmaceutical Technology Company Information
6.11.2 Hefei Home Sunshine Pharmaceutical Technology Description and Business Overview
6.11.3 Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Product Portfolio
6.11.5 Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
6.12 Sandoo Pharmaceuticals and Chemicals
6.12.1 Sandoo Pharmaceuticals and Chemicals Company Information
6.12.2 Sandoo Pharmaceuticals and Chemicals Description and Business Overview
6.12.3 Sandoo Pharmaceuticals and Chemicals Brigatinib API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sandoo Pharmaceuticals and Chemicals Brigatinib API Product Portfolio
6.12.5 Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Brigatinib API Industry Chain Analysis
7.2 Brigatinib API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Brigatinib API Production Mode & Process
7.4 Brigatinib API Sales and Marketing
7.4.1 Brigatinib API Sales Channels
7.4.2 Brigatinib API Distributors
7.5 Brigatinib API Customers
8 Brigatinib API Market Dynamics
8.1 Brigatinib API Industry Trends
8.2 Brigatinib API Market Drivers
8.3 Brigatinib API Market Challenges
8.4 Brigatinib API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ALK
Dr. Reddy’s Laboratories
LGC
Cayman Chemical
Conscientia Industrial
Manus Aktteva Biopharma LLP
Selleck
Shandong Sihuan Pharmaceutical
Vasudha Pharma
Hefei Home Sunshine Pharmaceutical Technology
Vitasv Pharma And Chemical
Anqing benro Pharmaceutical
Sandoo Pharmaceuticals and Chemicals
List of Tables
 Table 1. Global Brigatinib API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Brigatinib API Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Brigatinib API Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Brigatinib API Sales (kg) of Key Manufacturers (2019-2024)
 Table 5. Global Brigatinib API Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Brigatinib API Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Brigatinib API Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Brigatinib API Average Price (US$/kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Brigatinib API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Brigatinib API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Brigatinib API, Product Type & Application
 Table 12. Global Key Manufacturers of Brigatinib API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Brigatinib API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brigatinib API as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Brigatinib API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Brigatinib API Sales by Region (2019-2024) & (kg)
 Table 18. Global Brigatinib API Sales Market Share by Region (2019-2024)
 Table 19. Global Brigatinib API Sales by Region (2025-2030) & (kg)
 Table 20. Global Brigatinib API Sales Market Share by Region (2025-2030)
 Table 21. Global Brigatinib API Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Brigatinib API Revenue Market Share by Region (2019-2024)
 Table 23. Global Brigatinib API Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Brigatinib API Revenue Market Share by Region (2025-2030)
 Table 25. North America Brigatinib API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Brigatinib API Sales by Country (2019-2024) & (kg)
 Table 27. North America Brigatinib API Sales by Country (2025-2030) & (kg)
 Table 28. North America Brigatinib API Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Brigatinib API Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Brigatinib API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Brigatinib API Sales by Country (2019-2024) & (kg)
 Table 32. Europe Brigatinib API Sales by Country (2025-2030) & (kg)
 Table 33. Europe Brigatinib API Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Brigatinib API Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Brigatinib API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Brigatinib API Sales by Region (2019-2024) & (kg)
 Table 37. Asia Pacific Brigatinib API Sales by Region (2025-2030) & (kg)
 Table 38. Asia Pacific Brigatinib API Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Brigatinib API Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Brigatinib API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Brigatinib API Sales by Country (2019-2024) & (kg)
 Table 42. Latin America Brigatinib API Sales by Country (2025-2030) & (kg)
 Table 43. Latin America Brigatinib API Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Brigatinib API Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Brigatinib API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Brigatinib API Sales by Country (2019-2024) & (kg)
 Table 47. Middle East and Africa Brigatinib API Sales by Country (2025-2030) & (kg)
 Table 48. Middle East and Africa Brigatinib API Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Brigatinib API Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Brigatinib API Sales (kg) by Type (2019-2024)
 Table 51. Global Brigatinib API Sales (kg) by Type (2025-2030)
 Table 52. Global Brigatinib API Sales Market Share by Type (2019-2024)
 Table 53. Global Brigatinib API Sales Market Share by Type (2025-2030)
 Table 54. Global Brigatinib API Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Brigatinib API Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Brigatinib API Revenue Market Share by Type (2019-2024)
 Table 57. Global Brigatinib API Revenue Market Share by Type (2025-2030)
 Table 58. Global Brigatinib API Price (US$/kg) by Type (2019-2024)
 Table 59. Global Brigatinib API Price (US$/kg) by Type (2025-2030)
 Table 60. Global Brigatinib API Sales (kg) by Application (2019-2024)
 Table 61. Global Brigatinib API Sales (kg) by Application (2025-2030)
 Table 62. Global Brigatinib API Sales Market Share by Application (2019-2024)
 Table 63. Global Brigatinib API Sales Market Share by Application (2025-2030)
 Table 64. Global Brigatinib API Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Brigatinib API Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Brigatinib API Revenue Market Share by Application (2019-2024)
 Table 67. Global Brigatinib API Revenue Market Share by Application (2025-2030)
 Table 68. Global Brigatinib API Price (US$/kg) by Application (2019-2024)
 Table 69. Global Brigatinib API Price (US$/kg) by Application (2025-2030)
 Table 70. Dr. Reddy’s Laboratories Company Information
 Table 71. Dr. Reddy’s Laboratories Description and Business Overview
 Table 72. Dr. Reddy’s Laboratories Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 73. Dr. Reddy’s Laboratories Brigatinib API Product
 Table 74. Dr. Reddy’s Laboratories Recent Developments/Updates
 Table 75. Vitasv Pharma And Chemical Company Information
 Table 76. Vitasv Pharma And Chemical Description and Business Overview
 Table 77. Vitasv Pharma And Chemical Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 78. Vitasv Pharma And Chemical Brigatinib API Product
 Table 79. Vitasv Pharma And Chemical Recent Developments/Updates
 Table 80. LGC Company Information
 Table 81. LGC Description and Business Overview
 Table 82. LGC Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 83. LGC Brigatinib API Product
 Table 84. LGC Recent Developments/Updates
 Table 85. Cayman Chemical Company Information
 Table 86. Cayman Chemical Description and Business Overview
 Table 87. Cayman Chemical Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 88. Cayman Chemical Brigatinib API Product
 Table 89. Cayman Chemical Recent Developments/Updates
 Table 90. Conscientia Industrial Company Information
 Table 91. Conscientia Industrial Description and Business Overview
 Table 92. Conscientia Industrial Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 93. Conscientia Industrial Brigatinib API Product
 Table 94. Conscientia Industrial Recent Developments/Updates
 Table 95. Manus Aktteva Biopharma LLP Company Information
 Table 96. Manus Aktteva Biopharma LLP Description and Business Overview
 Table 97. Manus Aktteva Biopharma LLP Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 98. Manus Aktteva Biopharma LLP Brigatinib API Product
 Table 99. Manus Aktteva Biopharma LLP Recent Developments/Updates
 Table 100. Selleck Company Information
 Table 101. Selleck Description and Business Overview
 Table 102. Selleck Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 103. Selleck Brigatinib API Product
 Table 104. Selleck Recent Developments/Updates
 Table 105. Shandong Sihuan Pharmaceutical Company Information
 Table 106. Shandong Sihuan Pharmaceutical Description and Business Overview
 Table 107. Shandong Sihuan Pharmaceutical Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 108. Shandong Sihuan Pharmaceutical Brigatinib API Product
 Table 109. Shandong Sihuan Pharmaceutical Recent Developments/Updates
 Table 110. Anqing benro Pharmaceutical Company Information
 Table 111. Anqing benro Pharmaceutical Description and Business Overview
 Table 112. Anqing benro Pharmaceutical Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 113. Anqing benro Pharmaceutical Brigatinib API Product
 Table 114. Anqing benro Pharmaceutical Recent Developments/Updates
 Table 115. Vasudha Pharma Company Information
 Table 116. Vasudha Pharma Description and Business Overview
 Table 117. Vasudha Pharma Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 118. Vasudha Pharma Brigatinib API Product
 Table 119. Vasudha Pharma Recent Developments/Updates
 Table 120. Hefei Home Sunshine Pharmaceutical Technology Company Information
 Table 121. Hefei Home Sunshine Pharmaceutical Technology Description and Business Overview
 Table 122. Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 123. Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Product
 Table 124. Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
 Table 125. Sandoo Pharmaceuticals and Chemicals Company Information
 Table 126. Sandoo Pharmaceuticals and Chemicals Description and Business Overview
 Table 127. Sandoo Pharmaceuticals and Chemicals Brigatinib API Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 128. Sandoo Pharmaceuticals and Chemicals Brigatinib API Product
 Table 129. Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Brigatinib API Distributors List
 Table 133. Brigatinib API Customers List
 Table 134. Brigatinib API Market Trends
 Table 135. Brigatinib API Market Drivers
 Table 136. Brigatinib API Market Challenges
 Table 137. Brigatinib API Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Brigatinib API
 Figure 2. Global Brigatinib API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Brigatinib API Market Share by Type: 2023 & 2030
 Figure 4. Purity≥99% Product Picture
 Figure 5. Purity<99% Product Picture
 Figure 6. Global Brigatinib API Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Brigatinib API Market Share by Application: 2023 & 2030
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global Brigatinib API Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Brigatinib API Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Brigatinib API Sales (2019-2030) & (kg)
 Figure 13. Global Brigatinib API Average Price (US$/kg) & (2019-2030)
 Figure 14. Brigatinib API Report Years Considered
 Figure 15. Brigatinib API Sales Share by Manufacturers in 2023
 Figure 16. Global Brigatinib API Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Brigatinib API Players: Market Share by Revenue in Brigatinib API in 2023
 Figure 18. Brigatinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Brigatinib API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Brigatinib API Sales Market Share by Country (2019-2030)
 Figure 21. North America Brigatinib API Revenue Market Share by Country (2019-2030)
 Figure 22. United States Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Brigatinib API Sales Market Share by Country (2019-2030)
 Figure 25. Europe Brigatinib API Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Brigatinib API Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Brigatinib API Revenue Market Share by Region (2019-2030)
 Figure 33. China Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Brigatinib API Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Brigatinib API Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Brigatinib API Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Brigatinib API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Brigatinib API by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Brigatinib API by Type (2019-2030)
 Figure 52. Global Brigatinib API Price (US$/kg) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Brigatinib API by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Brigatinib API by Application (2019-2030)
 Figure 55. Global Brigatinib API Price (US$/kg) by Application (2019-2030)
 Figure 56. Brigatinib API Value Chain
 Figure 57. Brigatinib API Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Afatinib API Market Research Report 2024
Global Ceritinib API Market Research Report 2024
Global Crizotinib API Market Research Report 2024
Global Brigatinib Tablet Market Insights Forecast to 2030
Global Icotinib API Market Research Report 2024
Global Oncology API Market Research Report 2024
Alectinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sorafenib Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Olaparib API Market Research Report 2024
Global Pazopanib API Market Research Report 2025
Global Gilteritinib API Market Research Report 2024
Bosutinib API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dacomitinib API Market Research Report 2024
Global ALK Inhibitors Market Research Report 2024
Global Niraparib API Market Research Report 2024
Global Saracatinib Market Research Report 2024
Global Crizotinib Drugs Market Research Report 2024
Global Savolitinib Tablets Market Research Report 2024
Global Ensartinib Market Research Report 2024
Global BRAF Kinase Inhibitors Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions